Cargando…
Japanese pharmaceutical and regulatory environment
Drastic regulatory changes in Japan since 1997 have had a considerable impact on the way new medicines are developed. The regulatory authority itself has been transformed. Clinical trials are now performed according to international guidelines. Clinical data generated in one area are acceptable in t...
Autores principales: | Nagata, Ryoichi, Raflzadeh-Kabe, Jean-David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181698/ https://www.ncbi.nlm.nih.gov/pubmed/22034129 |
Ejemplares similares
-
Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
por: Nagata, Tomohisa, et al.
Publicado: (2018) -
Association between overtime work hours and preventive dental visits among Japanese workers
por: Harada, Yoshikazu, et al.
Publicado: (2021) -
Mammographic density and the risk of breast cancer in Japanese women
por: Nagata, C, et al.
Publicado: (2005) -
Special Issue “Pharmaceutical Residues in the Environment”
por: Kumirska, Jolanta
Publicado: (2020) -
Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)